Uploaded October 2025 | Updated November 2026, 3 days ago
Nicola Mason develops cancer immunotherapies for dogs that also accelerate novel clinical treatments for human patients.
To learn more about why Penn matters, visit www.upenn.edu/about/penn-matters
Nicola Mason develops cancer immunotherapies for dogs that also accelerate novel clinical treatments for human patients.
To learn more about why Penn matters, visit www.upenn.edu/about/penn-matters










